EP0378676A4 - Tumor necrosis enhancing factor and methods of preparation and use - Google Patents

Tumor necrosis enhancing factor and methods of preparation and use

Info

Publication number
EP0378676A4
EP0378676A4 EP19890908921 EP89908921A EP0378676A4 EP 0378676 A4 EP0378676 A4 EP 0378676A4 EP 19890908921 EP19890908921 EP 19890908921 EP 89908921 A EP89908921 A EP 89908921A EP 0378676 A4 EP0378676 A4 EP 0378676A4
Authority
EP
European Patent Office
Prior art keywords
preparation
methods
tumor necrosis
enhancing factor
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19890908921
Other versions
EP0378676A1 (en
Inventor
David M. Stern
Peter Nawroth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of EP0378676A1 publication Critical patent/EP0378676A1/en
Publication of EP0378676A4 publication Critical patent/EP0378676A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP19890908921 1988-07-15 1989-07-14 Tumor necrosis enhancing factor and methods of preparation and use Ceased EP0378676A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US219650 1980-12-24
US21965088A 1988-07-15 1988-07-15

Publications (2)

Publication Number Publication Date
EP0378676A1 EP0378676A1 (en) 1990-07-25
EP0378676A4 true EP0378676A4 (en) 1991-01-16

Family

ID=22820154

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890908921 Ceased EP0378676A4 (en) 1988-07-15 1989-07-14 Tumor necrosis enhancing factor and methods of preparation and use

Country Status (4)

Country Link
EP (1) EP0378676A4 (en)
JP (1) JPH03501620A (en)
AU (1) AU630106B2 (en)
WO (1) WO1990000400A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830448A (en) * 1994-06-16 1998-11-03 Genentech, Inc. Compositions and methods for the treatment of tumors
KR20180128097A (en) * 2012-02-10 2018-11-30 재패닉 코포레이션 Cosmetic product or skin regeneration promoter comprising nonhuman stem cell culture supernatant as starting material, and method for ion introduction for protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513124B1 (en) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab PRODUCTION AND APPLICATIONS OF THE TARGET CELL LYSE FACTOR
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
US4456550A (en) * 1982-11-22 1984-06-26 President And Fellows Of Harvard College Vascular permeability factor

Also Published As

Publication number Publication date
AU4034889A (en) 1990-02-05
EP0378676A1 (en) 1990-07-25
AU630106B2 (en) 1992-10-22
WO1990000400A1 (en) 1990-01-25
JPH03501620A (en) 1991-04-11

Similar Documents

Publication Publication Date Title
GB2158829B (en) Human tumor necrosis factor and dna therefor
AU7813191A (en) Novel immunoconjugates and methods for their use in tumor therapy
ZA876807B (en) Monoclonal antibodies against human tumor necrosis factor(tnf),and use thereof
AU584608B2 (en) DNA encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
GB2221390B (en) Niacin-containing composition and its therapeutic use
ZA844377B (en) The effect of human tumor necrosis factor and human interferon and human cancer cells and methods
IL90690A0 (en) Tissue equivalents and their preparation
JPS6454032A (en) Polydisilacyclobutasilazane and its preparation and use
AU5010685A (en) Human tumor necrosis factor
AU1346488A (en) Arginine-depleted human tumor necrosis factor
AU7117687A (en) Combination therapy using interleukin-2 and tumor necrosis factor
EP0378676A4 (en) Tumor necrosis enhancing factor and methods of preparation and use
EP0323645A3 (en) Extract of chlorella and use thereof
ZA857906B (en) Human tumor necrosis factor
GB8916320D0 (en) Preparation and use of dispersions
EP0324464A3 (en) Use of tnf and lt for preparation of medicaments
EP0393339A3 (en) Preparation of pre-caseinates, and use
HK1003571A1 (en) Alkenyltetrazole derivatives their preparation and use
GB2174090B (en) Improvement in the preparation and use of substituted bisphenols
IE882290L (en) Treatment of infections with tumor necrosis factor
EP0195681A3 (en) Tumor cytostatic-cytocidal factor and method of obtaining same
ZA872562B (en) Combination therapy using interleukin-2 and/or interferon-beta and tumor necrosis factor
ZA893970B (en) Methods of construction and implements therefor
CS856488A1 (en) 3-allyl-6-nitro-2-benzothiazolinone and method of its preparation
CS120788A1 (en) 2-bromomethylphenylisocyanate and method of its preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19900712

A4 Supplementary search report drawn up and despatched

Effective date: 19901126

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19921228

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19941226